Veeva Systems Inc. (VEEV) EV/EBITDA Ratio: 19.17x
Is Veeva Systems Inc.’s EV/EBITDA ratio high or low?
Veeva Systems Inc.'s EV/EBITDA ratio of 19.17x is 64% below its 5-year average of 53.99x, near the low end of its 5-year range (19.17x–121.26x).
As of Sunday, June 14, 2026. 42.31% below its 12-month average of 33.23x.
VEEV EV/EBITDA Ratio Chart
VEEV Average EV/EBITDA Ratio Chart
VEEV Current vs Average EV/EBITDA Ratio Chart
VEEV EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
19.17x
EV/EBITDA RATIO AVG TTM
33.23x
EV/EBITDA RATIO AVG 3Y
43.96x
EV/EBITDA RATIO AVG 5Y
53.99x
EV/EBITDA RATIO AVG 10Y
68.19x
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-42.31%
CURRENT VS 3Y AVG
-56.39%
CURRENT VS 5Y AVG
-64.50%
CURRENT VS 10Y AVG
-71.89%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
VEEV Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Veeva Systems Inc. (VEEV) | $25.92B | 19.17x | 33.23x | 43.96x | 53.99x |
| Waters Corporation (WAT)vs › | $23.17B | 37.11x | 21.72x | 21.28x | 21.47x |
| United Therapeutics Corporation (UTHR)vs › | $23.17B | 14.41x | 11.89x | 10.20x | 11.38x |
| BioNTech SE (BNTX)vs › | $22.90B | N/A | 51.40x | 19.63x | 20.05x |
| Mettler-Toledo International Inc. (MTD)vs › | $22.86B | 20.60x | 23.58x | 23.88x | 26.49x |
| DexCom, Inc. (DXCM)vs › | $29.08B | 20.28x | 25.32x | 42.50x | 70.63x |
| Biogen Inc. (BIIB)vs › | $29.53B | 12.16x | 8.71x | 11.20x | 12.24x |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | 13.73x | 14.69x | 14.58x | 11.71x |
| IQVIA Holdings Inc. (IQV)vs › | $30.29B | 12.77x | 13.60x | 15.11x | 17.15x |
| Medline Inc. (MDLN)vs › | $30.96B | 14.87x | 16.18x | 16.18x | 16.18x |
EV/EBITDA vs. its own history
At 19.2, EV/EBITDA is cheaper than usual, sitting higher than 0% of its 13-year history.
13-year low
19.2
median
61.3
13-year high
166.5
Veeva Systems Inc. EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Veeva Systems Inc. EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Veeva Systems Inc. (VEEV)?
- The EV/EBITDA ratio for VEEV stock is 19.17x.
- Is Veeva Systems Inc.'s EV/EBITDA ratio high or low?
- Veeva Systems Inc.'s EV/EBITDA ratio of 19.17x is 64% below its 5-year average of 53.99x, near the low end of its 5-year range (19.17x–121.26x).
- What is the TTM average EV/EBITDA ratio for Veeva Systems Inc. (VEEV)?
- The TTM average EV/EBITDA ratio for VEEV stock is 33.23x.
- What is the 3Y average EV/EBITDA ratio for Veeva Systems Inc. (VEEV)?
- The 3Y average EV/EBITDA ratio for VEEV stock is 43.96x.
- What is the 5Y average EV/EBITDA ratio for Veeva Systems Inc. (VEEV)?
- The 5Y average EV/EBITDA ratio for VEEV stock is 53.99x.
- What is the 10Y average EV/EBITDA ratio for Veeva Systems Inc. (VEEV)?
- The 10Y average EV/EBITDA ratio for VEEV stock is 68.19x.
Veeva Systems Inc. EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-12 | 19.17x |
| 2026-06-11 | 19.42x |
| 2026-06-10 | 19.71x |
| 2026-06-09 | 20.21x |
| 2026-06-08 | 20.16x |
| 2026-06-05 | 20.85x |
| 2026-06-04 | 23.27x |
| 2026-06-03 | 23.29x |
| 2026-06-02 | 23.86x |
| 2026-06-01 | 24.64x |
| 2026-05-29 | 22.69x |
| 2026-05-28 | 21.33x |
| 2026-05-27 | 20.53x |
| 2026-05-26 | 20.54x |
| 2026-05-22 | 20.76x |
| 2026-05-21 | 20.50x |
| 2026-05-20 | 21.41x |
| 2026-05-19 | 21.19x |
| 2026-05-18 | 21.26x |
| 2026-05-15 | 20.58x |
| 2026-05-14 | 20.22x |
| 2026-05-13 | 20.15x |
| 2026-05-12 | 20.66x |
| 2026-05-11 | 20.64x |
| 2026-05-08 | 21.60x |
| 2026-05-07 | 21.86x |
| 2026-05-06 | 21.74x |
| 2026-05-05 | 22.26x |
| 2026-05-04 | 22.13x |
| 2026-05-01 | 22.32x |
| 2026-04-30 | 20.19x |
| 2026-04-29 | 20.49x |
| 2026-04-28 | 20.53x |
| 2026-04-27 | 20.80x |
| 2026-04-24 | 20.89x |
| 2026-04-23 | 20.21x |
| 2026-04-22 | 21.25x |
| 2026-04-21 | 21.80x |
| 2026-04-20 | 21.94x |
| 2026-04-17 | 21.82x |
| 2026-04-16 | 21.78x |
| 2026-04-15 | 21.73x |
| 2026-04-14 | 20.61x |
| 2026-04-13 | 20.52x |
| 2026-04-10 | 19.57x |
| 2026-04-09 | 20.34x |
| 2026-04-08 | 21.63x |
| 2026-04-07 | 22.44x |
| 2026-04-06 | 22.73x |
| 2026-04-02 | 22.64x |
| 2026-04-01 | 22.47x |
| 2026-03-31 | 22.87x |
| 2026-03-30 | 22.91x |
| 2026-03-27 | 22.45x |
| 2026-03-26 | 23.23x |
| 2026-03-25 | 23.20x |
| 2026-03-24 | 23.34x |
| 2026-03-23 | 24.17x |
| 2026-03-20 | 24.02x |
| 2026-03-19 | 25.26x |
| 2026-03-18 | 25.03x |
| 2026-03-17 | 25.42x |
| 2026-03-16 | 25.21x |
| 2026-03-13 | 24.30x |
| 2026-03-12 | 24.57x |
| 2026-03-11 | 25.47x |
| 2026-03-10 | 25.85x |
| 2026-03-09 | 26.69x |
| 2026-03-06 | 26.68x |
| 2026-03-05 | 26.74x |
| 2026-03-04 | 25.67x |
| 2026-03-03 | 25.30x |
| 2026-03-02 | 24.66x |
| 2026-02-27 | 24.74x |
| 2026-02-26 | 24.87x |
| 2026-02-25 | 23.95x |
| 2026-02-24 | 23.85x |
| 2026-02-23 | 23.33x |
| 2026-02-20 | 24.50x |
| 2026-02-19 | 24.82x |
| 2026-02-18 | 24.64x |
| 2026-02-17 | 24.00x |
| 2026-02-13 | 23.61x |
| 2026-02-12 | 23.31x |
| 2026-02-11 | 24.03x |
| 2026-02-10 | 25.46x |
| 2026-02-09 | 25.12x |
| 2026-02-06 | 24.98x |
| 2026-02-05 | 25.01x |
| 2026-02-04 | 25.99x |
| 2026-02-03 | 26.00x |
| 2026-02-02 | 27.80x |
| 2026-01-30 | 27.88x |
| 2026-01-29 | 28.75x |
| 2026-01-28 | 29.90x |
| 2026-01-27 | 29.88x |
| 2026-01-26 | 30.79x |
| 2026-01-23 | 30.48x |
| 2026-01-22 | 30.95x |
| 2026-01-21 | 30.15x |
| 2026-01-20 | 29.65x |
| 2026-01-16 | 30.51x |
| 2026-01-15 | 30.04x |
| 2026-01-14 | 30.03x |
| 2026-01-13 | 31.41x |
| 2026-01-12 | 32.08x |
| 2026-01-09 | 33.07x |
| 2026-01-08 | 33.22x |
| 2026-01-07 | 32.96x |
| 2026-01-06 | 32.75x |
| 2026-01-05 | 30.38x |
| 2026-01-02 | 30.12x |
| 2025-12-31 | 30.65x |
| 2025-12-30 | 30.85x |
| 2025-12-29 | 30.91x |
| 2025-12-26 | 30.86x |
| 2025-12-24 | 30.64x |
| 2025-12-23 | 30.80x |
| 2025-12-22 | 30.67x |
| 2025-12-19 | 30.46x |
| 2025-12-18 | 29.92x |
| 2025-12-17 | 29.54x |
| 2025-12-16 | 30.09x |
| 2025-12-15 | 30.20x |
| 2025-12-12 | 30.66x |
| 2025-12-11 | 31.55x |
| 2025-12-10 | 31.50x |
| 2025-12-09 | 31.91x |
| 2025-12-08 | 32.92x |
| 2025-12-05 | 33.34x |
| 2025-12-04 | 33.38x |
| 2025-12-03 | 33.25x |
| 2025-12-02 | 33.08x |
| 2025-12-01 | 33.11x |
| 2025-11-28 | 33.10x |
| 2025-11-26 | 33.15x |
| 2025-11-25 | 33.05x |
| 2025-11-24 | 32.44x |
| 2025-11-21 | 33.64x |
| 2025-11-20 | 39.77x |
| 2025-11-19 | 40.15x |
| 2025-11-18 | 40.26x |
| 2025-11-17 | 40.76x |
| 2025-11-14 | 43.27x |
| 2025-11-13 | 43.02x |
| 2025-11-12 | 43.82x |
| 2025-11-11 | 44.15x |
| 2025-11-10 | 43.64x |
| 2025-11-07 | 43.50x |
| 2025-11-06 | 42.94x |
| 2025-11-05 | 43.56x |
| 2025-11-04 | 43.29x |
| 2025-11-03 | 43.17x |
| 2025-10-31 | 42.94x |
| 2025-10-30 | 41.99x |
| 2025-10-29 | 42.24x |
| 2025-10-28 | 42.96x |
| 2025-10-27 | 43.63x |
| 2025-10-24 | 43.22x |
| 2025-10-23 | 42.99x |
| 2025-10-22 | 42.75x |
| 2025-10-21 | 42.73x |
| 2025-10-20 | 42.13x |
| 2025-10-17 | 41.79x |
| 2025-10-16 | 43.17x |
| 2025-10-15 | 42.35x |
| 2025-10-14 | 42.40x |
| 2025-10-13 | 42.16x |
| 2025-10-10 | 42.23x |
| 2025-10-09 | 44.05x |
| 2025-10-08 | 44.56x |
| 2025-10-07 | 45.24x |
| 2025-10-06 | 44.25x |
| 2025-10-03 | 43.72x |
| 2025-10-02 | 44.41x |
| 2025-10-01 | 43.25x |
| 2025-09-30 | 43.97x |
| 2025-09-29 | 43.22x |
| 2025-09-26 | 42.80x |
| 2025-09-25 | 41.21x |
| 2025-09-24 | 40.91x |
| 2025-09-23 | 41.04x |
| 2025-09-22 | 41.39x |
| 2025-09-19 | 40.88x |
| 2025-09-18 | 41.08x |
| 2025-09-17 | 40.39x |
| 2025-09-16 | 40.28x |
| 2025-09-15 | 40.65x |
| 2025-09-12 | 40.68x |
| 2025-09-11 | 41.14x |
| 2025-09-10 | 40.40x |
| 2025-09-09 | 41.63x |
| 2025-09-08 | 41.65x |
| 2025-09-05 | 40.14x |
| 2025-09-04 | 39.70x |
| 2025-09-03 | 39.84x |
| 2025-09-02 | 39.69x |
| 2025-08-29 | 39.57x |
| 2025-08-28 | 41.24x |
| 2025-08-27 | 44.60x |
| 2025-08-26 | 43.48x |
| 2025-08-25 | 43.27x |
| 2025-08-22 | 44.16x |
| 2025-08-21 | 42.81x |
| 2025-08-20 | 43.08x |
| 2025-08-19 | 43.14x |
| 2025-08-18 | 42.78x |
| 2025-08-15 | 42.55x |
| 2025-08-14 | 41.66x |
| 2025-08-13 | 42.32x |
| 2025-08-12 | 41.73x |
| 2025-08-11 | 41.97x |
| 2025-08-08 | 42.79x |
| 2025-08-07 | 42.41x |
| 2025-08-06 | 42.87x |
| 2025-08-05 | 42.68x |
| 2025-08-04 | 43.28x |
| 2025-08-01 | 42.66x |
| 2025-07-31 | 43.11x |
| 2025-07-30 | 43.54x |
| 2025-07-29 | 43.59x |
| 2025-07-28 | 44.44x |
| 2025-07-25 | 44.09x |
| 2025-07-24 | 44.23x |
| 2025-07-23 | 43.40x |
| 2025-07-22 | 43.27x |
| 2025-07-21 | 42.61x |
| 2025-07-18 | 42.81x |
| 2025-07-17 | 41.89x |
| 2025-07-16 | 42.84x |
| 2025-07-15 | 42.34x |
| 2025-07-14 | 42.81x |
| 2025-07-11 | 41.80x |
| 2025-07-10 | 42.71x |
| 2025-07-09 | 43.14x |
| 2025-07-08 | 42.55x |
| 2025-07-07 | 42.61x |
| 2025-07-03 | 43.13x |
| 2025-07-02 | 42.86x |
| 2025-07-01 | 42.91x |
| 2025-06-30 | 43.71x |
| 2025-06-27 | 42.99x |
| 2025-06-26 | 42.64x |
| 2025-06-25 | 42.37x |
| 2025-06-24 | 42.71x |
| 2025-06-23 | 42.50x |
| 2025-06-20 | 42.46x |
| 2025-06-18 | 42.67x |
| 2025-06-17 | 42.75x |
| 2025-06-16 | 43.17x |
| 2025-06-13 | 42.85x |
| 2025-06-12 | 42.79x |
| 2025-06-11 | 43.80x |
| 2025-06-10 | 43.10x |
| 2025-06-09 | 42.97x |
| 2025-06-06 | 43.30x |
| 2025-06-05 | 44.02x |
| 2025-06-04 | 43.01x |
| 2025-06-03 | 43.20x |
| 2025-06-02 | 42.23x |
Showing the most recent 260 of 3,183 data points. The chart above shows the full history.
Related Metrics
About Veeva Systems Inc.
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Peter Gassner